The morphology of hydroxyapatite microspheres can materially change how they degrade, making particle design central to formulation strategy.
For biomaterials teams, composition, structure, process control, and end-use requirements should be reviewed together, because each one affects performance in the final application.
For that reason, material selection, manufacturing consistency, and the actual application context should be assessed together rather than in isolation.